Recent news on

Nanoparticles delivery of "Suicide DNA" kills prostate tumors  -  May 22, 2007
Nanowerk LLC,Without this protein, the diphtheria toxin gene remains inactive, which makes it non-toxic to any cells but those in the prostate.

On a mission for a drug  -  Apr 5, 2007
Philadelphia Inquirer,When TransMid attaches to transferrin receptors on cancer cells, the diphtheria toxin slips into the cells, ultimately killing them.

Eric Vivier’s Team at the Marseille-luminy Immunology Centre and ...  -  Feb 28, 2007
PharmaLive.com (press release),Different transgenic mice have been produced either by transferring the diphtheria toxin receptor or the NKp46 human gene or of the green fluorescent

Scorpion Poison May Destroy Cancer Cells  -  Feb 1, 2007
KSL-TV,Nationally, Diphtheria toxin trials were abandoned as of yesterday. And another bacterial toxin has been dropped as well. But yet, someone, like Jerod Swan

Celtic Pharma Terminates Transmid Trial KSB311R/CIII/001  -  Feb 7, 2007
PharmaLive.com (press release),TransMID is a product which consists of a modified diphtheria toxin conjugated with transferrin. Transferrin receptors are over expressed on the surface of

Full Text  -  Feb 1, 2007
Science Magazine (subscription)The scientists genetically engineered mice so that cells activating Pdx1 would also turn on an inserted gene that encodes diphtheria toxin--unless the

Second Statewide Research Summit Focuses on Addressing ...  -  Nov 28, 2006
U.S. Newswire (press release),...will report on preliminary results from a gene-therapy strategy for ovarian cancer that used nanoparticles to deliver a diphtheria toxin (DT-A) gene to

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional